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For most patients penicillin (IV) or 
amoxicillin (oral) are the preferred 
beta-lactam antibiotics. 
Ceftriaxone/cefotaxime should only 
be used for patients with mild-
moderate penicillin allergy or where 
penicillin resistant pneumococci are 
strongly suspected. 
Antibiotic therapy for 
community-acquired 
pneumonia in adults: 
Information for clinicians 
What is community-acquired pneumonia? 
Community acquired pneumonia (CAP) is defined as pneumonia occurring in individuals who are not in hospital (or have been in hospital 
for less than 48 hours) and who are not significantly immunocompromised.  
CAP in adults 
Choice of antibiotic is usually empirical because the aetiology is not known for at least 48 hours after admission.  An Australian study of 
CAP in adults has shown that the most common causes are respiratory viruses (15%), Streptococcus pneumoniae (14%), Mycoplasma 
pneumoniae (9%), Haemophilus influenzae (5%), Legionella species (3.%) and Chlamydophila (Chlamydia) species (2%).   In the major-
ity of cases no pathogens were isolated and it is assumed that viruses & S.pneumoniae were the most likely cause in those patients.
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Assessing adult patients with suspected CAP 
In patients with suspected pneumonia the following should be assessed: 
•  History and examination, chest X-ray, oxygen saturation 
•  Investigations for the causal pathogen - may include sputum (Gram stain and culture) and blood cultures  
•  Depending on clinical circumstances, other investigations may be ordered such as urinary antigen assay (pneumococcal & Le-
gionella), nose & throat swabs for respiratory viruses, serology (Mycoplasma, Legionella, Chlamydophila [Chlamydia]). 
•  Pneumonia severity score may be used to guide decisions about need for inpatient management and most appropriate empirical 
antibiotic therapy.  CORB & SMART-COP are based on predictors of requirement for intensive respiratory or vasopressor support 
and mortality and can be found in Therapeutic Guidelines: Antibiotic version 14. 
•  An algorithm adapted from the guidelines for initial antibiotic management is reproduced on the back page of this fact sheet.  For 
dosing information refer to Therapeutic Guidelines: Antibiotic available on CKN (Queensland Health intranet users only). 
Considerations when assessing CAP severity 
•  Management options based on severity scoring systems should only be considered as a guide.  The patients clinical and social con-
text should always be taken into account. 
•  Close clinical review during the initial 24 to 48 hours is essential as some patients may worsen during this period and management 
may need to change. 
Additional notes on management 
•  Once patients with CAP become clinically stable and can tolerate oral therapy, they should be switched from IV therapy. 
•  For IV therapy, benzyl penicillin is preferred to amoxy/ampicillin as it has similar efficacy against beta-lactamase negative H. influen-
zae, but a narrower spectrum of activity. 
•  For oral therapy, amoxycillin is preferred to phenoxymethylpenicillin because it has better absorption and is more active against H. 
influenzae. 
•  Penicillin-resistant S. pneumoniae and H. influenzae are uncommon causes of CAP in Australia and the routine use of ceftriaxone or 
cefotaxime for non severe CAP is not recommended as it provides no additional benefit over the penicillins.  These  drugs should be 
reserved for patients with mild to moderate penicillin allergy. 
•  Staphylococcus aureus is a rare cause of  severe CAP and usually occurs in the context of prior influenza A.  If it is suspected on the 
basis of an urgent sputum Gram stain, add vancomycin to the empiric regimen as non-multiresistant MRSA may be the cause. 
Other considerations in tropical regions 
In some tropical regions Burkholderia pseudomallei and Acinetobacter baumannii are important causes of severe CAP with the inci-
dence of B. pseudomallei second to S. pneumoniae.  Risk factors include diabetes, heavy alcohol consumption, chronic renal failure and 
chronic lung disease and in these cases a different initial therapy is required. 
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Key Points for Clinicians 
1.  Consider using CORB or SMART-COP to determine severity of pneumonia as part of initial assessment of patient with suspected 
CAP and use as a guide for empirical choice of antibiotic.  
2.  Penicillin (IV) or amoxicillin (oral) are the preferred beta-lactam antibiotics. 
3.  For patients with mild penicillin allergy IV cefotaxime/ceftriaxone or oral cefuroxime are the recommended alternatives. 
4.  Clinical review in the initial 24 - 48 hours is important. 
5.  Modify therapy after microbiological diagnosis is confirmed. 
6.  An early step down to oral therapy once the patient is stable is strongly recommended.  
Initial antibiotic management of community-acquired pneumonia in adults 
  Adapted from Therapeutic Guidelines:Antibiotic Version 14. 
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